continuous ambulatory peritoneal dialysis patients CAPD Peritonitis vitamin d deficiency
Conditions
Interventions
oral ergocalciforol 40,
000 iu/wk every 2 weeks,
totally 20 weeks,
total dose of ergocalciferol 800,
000 iu
standard treatment for CAPD and other comorbities ,standard treatment for CAPD and other comorbities
Experimental Drug,No Intervention No treatment
oral ergocalciferol and standard treatment ,standard treatment
Sponsors
Dialysis unit, department of medicine, kalasin hospital
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: ESRD on CAPD and stable run CAPD more than one month.
Exclusion criteria
Exclusion criteria: previous vitamin d intake previous peritonitis 3 months active cancer hypercalcemia with serum calcium >10.5 mg/dL iPTH < 50 pg/ml
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| peritonitis event 24 weeks Logrank test | — |
Secondary
| Measure | Time frame |
|---|---|
| Death from any cause infection 24 weeks Logrank test ,CVD death 24 weeks logrank test ,secondary hyperparathyroidism 24 weeks Z-test ,falling 24 weeks Z-test ,fracture 24 weeks Z-test ,depression 24 weeks Z-test ,anemia 24 weeks Z-test | — |
Countries
Thailand
Contacts
Public Contactkrittapong somboon
kalasin hospital
Outcome results
None listed